Results 131 to 140 of about 5,779,825 (391)
Right to science principles should guide global governance on health. [PDF]
Front Sociol, 2023 Dang G, Frick M.
europepmc +1 more source
Emerging Powers and Emerging Trends in Global Governance
Understanding Global Cooperation, 2017 In the 1990s, liberal optimism permeated the study and practice of international politics. International institutions were strengthened and the discourse and practice of global governance consolidated as a new approach to world affairs. Today, new powers
Matthew D. Stephen
semanticscholar +1 more source
Molecular Oncology, EarlyView.This nationwide study evaluated KRAS and NRAS mutations in 10 754 Turkish patients with metastatic colorectal cancer. The results revealed a mutation frequency of 51.1%, with 46.6% having KRAS mutations, 4.5% having NRAS mutations, and 48.5% being wild‐type for both.
Gozde Kavgaci +6 more
wiley +1 more source
Global governance for pandemic prevention and the wildlife trade. [PDF]
Lancet Planet Health, 2023 Gallo-Cajiao E +14 more
europepmc +1 more source
Infrastructure for sustainable development: the role of national development banks [PDF]
, 2016 This repository item contains a policy brief from the Boston University Global Economic Governance Initiative. The Global Economic Governance Initiative (GEGI) is a research program of the Center for Finance, Law & Policy, the Frederick S.
Gallagher, Kevin P., Yuan, Fei
core +1 more source
Loss of proton‐sensing GPR4 reduces tumor progression in mouse models of colon cancer
Molecular Oncology, EarlyView.G protein‐coupled receptor 4 (GPR4) is a pH‐sensing receptor activated by acidic pH. GPR4 expression is increased in patients with inflammatory bowel disease who are at high risk of developing colorectal cancer. In mouse models, loss of GPR4 attenuated tumor progression. This correlated with increased IL2 and natural killer cell activity.
Leonie Perren +16 more
wiley +1 more source
Good Governance and Trade Policy: Are They the Keys to Africa's Global Integration and Growth? [PDF]
, 1999 Francis Ng, Alexander J. Yeats
openalex +1 more source
Molecular Oncology, EarlyView.In patients treated with atezolizumab as a part of the MyPathway (NCT02091141) trial, pre‐treatment ctDNA tumor fraction at high levels was associated with poor outcomes (radiographic response, progression‐free survival, and overall survival) but better sensitivity for blood tumor mutational burden (bTMB).
Charles Swanton +17 more
wiley +1 more source
Governance in Global Value Chains [PDF]
, 2001 John Humphrey, Hubert Schmitz
openalex +2 more sources